Prospective, Multi-center, Randomized, Parallel-control, Superiority Study Comparing Administration of Clotting Factor Concentrates With a Standard Massive Hemorrhage Protocol in Severely Bleeding Trauma Patients
Latest Information Update: 07 Dec 2022
At a glance
- Drugs Fibrinogen (Primary) ; Prothrombin complex concentrate (Primary)
- Indications Haemorrhage; Wounds and injuries
- Focus Therapeutic Use
- Acronyms FiiRST-2
- 04 Jul 2022 According to OctaPharma media release, data from this study will be featured in poster presentations and two Supported Symposia during ISTH 2022 Congress major international meeting
- 01 Apr 2021 Status changed from not yet recruiting to recruiting.
- 16 Dec 2020 Planned End Date changed from 30 Jun 2023 to 30 Jan 2024.